Breastfeeding may be protective against postpartum relapses in multiple sclerosis (MS), according to a review and meta-analysis published online in JAMA Neurology.
Postpartum depression is complex—and so is the first FDA-approved treatment. The 60-hour inpatient infusion process for Sage Therapeutics' Zulresso calls for more than the typical information and education.